CN1562391A - Mineralized composite material of gene recombination collagen and preparation method - Google Patents
Mineralized composite material of gene recombination collagen and preparation method Download PDFInfo
- Publication number
- CN1562391A CN1562391A CN 200410033774 CN200410033774A CN1562391A CN 1562391 A CN1562391 A CN 1562391A CN 200410033774 CN200410033774 CN 200410033774 CN 200410033774 A CN200410033774 A CN 200410033774A CN 1562391 A CN1562391 A CN 1562391A
- Authority
- CN
- China
- Prior art keywords
- collagen
- solution
- gene recombinaton
- calcium
- mineralising
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000008186 Collagen Human genes 0.000 title claims abstract description 65
- 108010035532 Collagen Proteins 0.000 title claims abstract description 65
- 229920001436 collagen Polymers 0.000 title claims abstract description 55
- 108090000623 proteins and genes Proteins 0.000 title claims description 46
- 239000002131 composite material Substances 0.000 title claims description 17
- 238000002360 preparation method Methods 0.000 title claims description 13
- 238000005215 recombination Methods 0.000 title 1
- 230000006798 recombination Effects 0.000 title 1
- 238000003756 stirring Methods 0.000 claims abstract description 17
- 229910001424 calcium ion Inorganic materials 0.000 claims abstract description 14
- 239000000203 mixture Substances 0.000 claims abstract description 14
- 238000004108 freeze drying Methods 0.000 claims abstract description 11
- 238000005406 washing Methods 0.000 claims abstract description 11
- 239000002253 acid Substances 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 150000002500 ions Chemical class 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 60
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 24
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 13
- 239000008367 deionised water Substances 0.000 claims description 12
- 229910021641 deionized water Inorganic materials 0.000 claims description 12
- 238000001556 precipitation Methods 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 12
- 239000011575 calcium Substances 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 229910019142 PO4 Inorganic materials 0.000 claims description 8
- 239000010452 phosphate Substances 0.000 claims description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical group [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 claims description 6
- 159000000007 calcium salts Chemical class 0.000 claims description 6
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 6
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 5
- 239000003513 alkali Substances 0.000 claims description 5
- 229910052791 calcium Inorganic materials 0.000 claims description 5
- CUXQLKLUPGTTKL-UHFFFAOYSA-M microcosmic salt Chemical compound [NH4+].[Na+].OP([O-])([O-])=O CUXQLKLUPGTTKL-UHFFFAOYSA-M 0.000 claims description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- 239000013078 crystal Substances 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 4
- -1 phosphate anion Chemical class 0.000 claims description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 3
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- OYTKINVCDFNREN-UHFFFAOYSA-N amifampridine Chemical compound NC1=CC=NC=C1N OYTKINVCDFNREN-UHFFFAOYSA-N 0.000 claims description 3
- LFVGISIMTYGQHF-UHFFFAOYSA-N ammonium dihydrogen phosphate Chemical compound [NH4+].OP(O)([O-])=O LFVGISIMTYGQHF-UHFFFAOYSA-N 0.000 claims description 3
- 239000000908 ammonium hydroxide Substances 0.000 claims description 3
- 239000001110 calcium chloride Substances 0.000 claims description 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 3
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims description 3
- 239000000920 calcium hydroxide Substances 0.000 claims description 3
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims description 3
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 3
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 3
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 3
- 235000019800 disodium phosphate Nutrition 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 3
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 3
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 3
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 3
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 3
- 239000011574 phosphorus Substances 0.000 claims description 3
- 229910052698 phosphorus Inorganic materials 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 3
- 108010043741 Collagen Type VI Proteins 0.000 claims description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 238000004140 cleaning Methods 0.000 claims description 2
- 229910017604 nitric acid Inorganic materials 0.000 claims description 2
- 239000002244 precipitate Substances 0.000 claims description 2
- 210000000988 bone and bone Anatomy 0.000 abstract description 12
- 238000000926 separation method Methods 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 238000003760 magnetic stirring Methods 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 241000255789 Bombyx mori Species 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000000227 bioadhesive Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000012407 engineering method Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A mineralized genetically recombinant collagen composition for repairing bone is prepared through preparing the solution of genetically recombinant collagen in acid or water, dropping Ca ions contained solution in it while stirring, adding PO4 ions contained solution, regulating pH value, stirring, laying aside, centrifugal separation and washing several times, and freeze drying. It has high biocompatibility.
Description
Technical field
The present invention relates to a kind of mineralising gene recombinaton collagen composite materials and preparation method thereof, belong to technical field of bioengineering.
Background technology
Collagen protein is the extremely important structural protein of connective tissue, plays the function that supports organ, protection body.Collagen protein is the maximum protein of people's in-vivo content, accounts for the 25%-30% of body internal protein total amount, is equivalent to 6% of body weight.The collagen protein product is widely used in industries such as medical science, beauty treatment, cosmetics, but home and abroad no matter at present, it is produced and all adopts animal skins, heel string, cartilage and human placental extract, and all there are problems such as viral hidden danger, immunoreation or ethics in the collagen that extracts by these methods.Along with engineered development, the dna recombinant expression technology is applied to the production of recombinant collagen.The gene recombinaton collagen protein is a kind of high-molecular biologic albumen that adopts technique for gene engineering to produce, and its basic skills is to extract certain segment DNA of expressing human collagen, carry out certain modification after, in expression vector, express.A series of expression systems such as mammalian cell, silkworm, insect cell, yeast cells, escherichia coli all can be used for the production of serial recombinant collagen at present.The recombinant collagen of producing as Xi'an giant's biotechnology limited company is to become cDNA to be reconstituted in the escherichia coli after particular sequence repeats and modifies through the fragment gene behind the enzyme action the proteic mRNA reverse transcription of human collagen, and obtained high expressed, through a kind of gene recombinaton collagen of high density fermentation, separation, purifying process production.(Chinese patent application number 01106757.8 publication number CN1371919A)
Compare with the animal sources collagen protein, the gene recombinaton collagen protein not only has the inherent character of collagen protein, as: biocompatibility, biological degradability and absorbability, bioadhesive, short new cell form and urge epithelial cell and form, and have characteristics such as virus-free hidden danger, machinability and low rejection, can be widely used in a plurality of industries such as medical science, beauty treatment, health product and cosmetics.So adopt gene recombinaton collagen among the present invention.
Present clinical bone reparation is used to exist the danger of originating shortage, immunologic rejection and catching from body bone and allograph bone.The main component of biological osseous tissue is collagen protein and hydroxyapatite.Pure hydroxyapatite has excellent biocompatibility, bone conductibility and biological activity, has been widely used in the operation of plastic surgery operations and tooth section.But pure hydroxyapatite fragility is big, poor toughness, and easily come off from implant site, limited its use clinically.Chinese invention patent (application number 00107493.8, publication number CN 1272383A) discloses and has a kind ofly improved the character bionics method for preparation of hydroxyapatite with collagen protein, has obtained the good medical treatment effect.But because present used collagen protein is mainly derived from animal, have viral hidden danger, and the reorganization recombined collagen that adopts gene engineering method to produce can be avoided this problem.
Summary of the invention
One of purpose of the present invention provides a kind of mineralising gene recombinaton collagen composite materials that bone is repaired that can be used for, and another purpose provides the preparation method of mineralising gene recombinaton collagen composite materials.
The mineralising gene recombinaton collagen composite materials that the present invention proposes, it is characterized in that: contain organic composition and mineral in this material, described organic principle is a gene recombinaton collagen, described mineral is a calcium microcosmic salt crystal.
In above-mentioned mineralising gene recombinaton collagen composite materials, described gene recombinaton collagen, relative molecular weight are 10,000~400,000.
In above-mentioned mineralising gene recombinaton collagen composite materials, described gene recombinaton collagen is that the segment of choosing human I, II, III, IV, V, VI, XI Collagen Type VI gene is modified the back expression.。
In above-mentioned mineralising gene recombinaton collagen composite materials, described calcium microcosmic salt crystal comprises hydroxyapatite.
The preparation method of the mineralising gene recombinaton collagen composite materials that the present invention proposes, it is characterized in that: described method comprises the following steps:
(1) drip the solution that contains calcium ion in the gene recombinaton collagen solution, make the mass percent concentration of recombinant collagen in the solution finally be 0.3%-30%, the molar concentration of calcium ion finally is 0.01~2mol/L, needs continuous stirring in the dropping process; Can adopt acid or deionized water dissolving for water solublity gene recombinaton collagen, for non-water-soluble employing acid dissolving, used acid is hydrochloric acid, acetic acid, nitric acid, slowly adds the solution that contains calcium ion in this solution, and dripping quantity is that every grammes per square metre group collagen drips calcium ion 0.01~1mol;
(2) drip the aqueous solution contain phosphate anion while stirring slowly in the solution of step (1), the phosphate anion of adding and the mol ratio of calcium ion are Ca: P=1~2: 1;
(3) pH value of dripping alkali liquid adjusting while stirring is 7.4~13 in the solution of step (2);
(4) will leave standstill after the solution stirring, treat precipitation and supernatant layering after, remove supernatant, centrifugalize goes out precipitation, removes the solubility salinity with the deionized water cyclic washing, makes cleaning mixture be neutrality;
(5) precipitate is put into the freeze dryer lyophilization, subsequently dry thing is ground, promptly get described mineralising gene recombinaton collagen composite materials.
In above-mentioned preparation method, the solution of the described calcium ions of step (1) is any in calcium hydroxide and the calcium salt, and calcium salt is preferably lime nitrate, calcium chloride;
In above-mentioned preparation method, the solution of the described phosphorus-containing acid ion of step (2) is phosphoric acid and phosphatic any, and phosphate is preferably sodium dihydrogen phosphate, sodium hydrogen phosphate, potassium dihydrogen phosphate, dipotassium hydrogen phosphate, DAP, ammonium di-hydrogen phosphate.
In above-mentioned preparation method, the described alkali liquor of step (3) is alkali metal hydroxide or ammonium hydroxide, is preferably sodium hydroxide.
Use proof:, have the hidden danger of cross infection because the mineralising gene recombinaton collagen-based materials that the present invention adopts bone to repair has avoided collagen base bone material both domestic and external before this all with the collagen of animal extraction.Prepared material has the characteristics of virus-free hidden danger and low immunity rejection property, and good biocompatibility, but induction of bone growth, its calcium microcosmic salt crystalline size can be used for preparing the bone alternate material of biological property excellence in nanometer scale.In addition, this material combines this material from composition and the imitative nature bone of structure with other frame material, and can be used for preparing has the excellent biological property and the bone renovating material of mechanical property.
The specific embodiment
The present invention will be further described below in conjunction with embodiment:
Solid content 1%) and solid-state (purity 99%) recombinant collagen used gene recombinaton collagen is Xi'an giant's biotechnology limited company liquid state of producing (concentration: among the present invention.
The solution of used phosphorus-containing acid ion is phosphoric acid and phosphate among the present invention, and used phosphate can be sodium dihydrogen phosphate, sodium hydrogen phosphate, potassium dihydrogen phosphate, dipotassium hydrogen phosphate, DAP, ammonium di-hydrogen phosphate; The solution of used calcium ions can be calcium hydroxide and calcium salt, and calcium salt can be lime nitrate, calcium chloride; Used alkali liquor can be alkali metal hydroxide or ammonium hydroxide, selects sodium hydroxide in the test for use.Agents useful for same is analytical pure.
Embodiment 1
1) in the concentration that mixes up was 0.9% 500ml gene recombinaton collagen solution, Dropwise 5 00ml concentration was the Ca (OH) of 0.25mol/L
2Behind the solution, continuing slowly to add concentration is the NaH of 0.25mol/L
2PO
4Solution 300ml uses the magnetic stirring apparatus mix homogeneously in the time of dropping.
2) above-mentioned system is stirred, leaves standstill, remove supernatant, centrifugalize goes out precipitation, after removing salinity wherein and reach neutrality with the deionized water cyclic washing, puts into the freeze dryer lyophilization, dry thing is ground make dry powder subsequently.
Embodiment 2
1) in the concentration that mixes up is 33% 450ml gene recombinaton collagen solution, adding 25ml concentration is the CaCl of 0.2mol/L
2Behind the solution, continuing slowly to drip concentration is the Na of 0.2mol/L
2HPO
4Solution 25ml uses the magnetic stirring apparatus mix homogeneously in the time of dropping.
2) in the solution of the above-mentioned first step, slowly drip NaOH solution while stirring, stabilize to 7.4 until pH value.
3) above-mentioned system is stirred, leaves standstill, remove supernatant, centrifugalize goes out precipitation, after removing salinity wherein and reach neutrality with the deionized water cyclic washing, puts into the freeze dryer lyophilization, dry thing is ground make dry powder subsequently.
Embodiment 3
1) in the concentration that mixes up is 10% 100ml gene recombinaton collagen solution, adding concentration is the KH of 2mol/L
2PO
4Solution 500ml, continuing slowly to drip 400ml concentration is the Ca (NO of 5mol/L
3)
2Behind the solution, use the magnetic stirring apparatus mix homogeneously in the time of dropping.
2) slowly dripping KOH solution while stirring in the solution of the above-mentioned first step, is 8.0 until pH value.
3) above-mentioned system is stirred, leaves standstill, remove supernatant, centrifugalize goes out precipitation, after removing salinity wherein and reach neutrality with the deionized water cyclic washing, puts into the freeze dryer lyophilization, dry thing is ground make dry powder subsequently.
Embodiment 4
1) in the concentration that mixes up is 25% 450ml gene recombinaton collagen solution, adding 25ml concentration is the CaCl of 0.2mol/L
2Behind the solution, continuing slowly to drip concentration is the NH of 0.2mol/L
3H
2PO
4Solution 25ml uses the magnetic stirring apparatus mix homogeneously in the time of dropping.
2) in the solution of the above-mentioned first step, slowly drip NaOH solution while stirring, stabilize to 10.0 until pH value.
3) above-mentioned system is stirred, leaves standstill, remove supernatant, centrifugalize goes out precipitation, after removing salinity wherein and reach neutrality with the deionized water cyclic washing, puts into the freeze dryer lyophilization, dry thing is ground make dry powder subsequently.
Embodiment 5
1) concentration that mixes up is in 25% the 200ml gene recombinaton collagen solution, and adding concentration is the K of 2mol/L
2HPO
4Solution 500ml, continuing slowly to drip 300ml concentration is the Ca (NO of 5mol/L
3)
2Behind the solution, use the magnetic stirring apparatus mix homogeneously in the time of dropping.
2) slowly dripping KOH solution while stirring in the solution of the above-mentioned first step, is 13.0 until pH value.
3) above-mentioned system is stirred, leaves standstill, remove supernatant, centrifugalize goes out precipitation, after removing salinity wherein and reach neutrality with the deionized water cyclic washing, puts into the freeze dryer lyophilization, dry thing is ground make dry powder subsequently.
Embodiment 6
1) in the concentration that mixes up is 15% 200ml gene recombinaton collagen solution, adding 500ml concentration is the CaCl of 0.2mol/L
2Behind the solution, continuing slowly to drip concentration is the H of 0.2mol/L
3PO
4Solution 300ml uses the magnetic stirring apparatus mix homogeneously in the time of dropping.
2) in the solution of the above-mentioned first step, slowly drip NaOH solution while stirring, reach 8.5 until pH value.
3) above-mentioned system is stirred, leaves standstill, remove supernatant, centrifugalize goes out precipitation, after removing salinity wherein and reach neutrality with the deionized water cyclic washing, puts into the freeze dryer lyophilization, dry thing is ground make dry powder subsequently.
Embodiment 7
1) concentration that mixes up is in 30% the 200ml gene recombinaton collagen solution, and adding 500ml concentration is the CaCl of 1mol/L
2Behind the solution, continuing slowly to drip concentration is the NaH of 0.7mol/L
2PO
4Solution 300ml uses the magnetic stirring apparatus mix homogeneously in the time of dropping.
2) in the solution of the above-mentioned first step, slowly drip NaOH solution while stirring, reach 9.0 until pH value.
3) above-mentioned system is stirred, leaves standstill, remove supernatant, centrifugalize goes out precipitation, after removing salinity wherein and reach neutrality with the deionized water cyclic washing, puts into the freeze dryer lyophilization, dry thing is ground make dry powder subsequently.
Embodiment 8
1) in the concentration that mixes up is 25% 450ml gene recombinaton collagen solution, adding 25ml concentration is the Ca (NO of 1mol/L
3)
2Behind the solution, continuing slowly to drip concentration is the KH of 1mol/L
2PO
4Solution 25ml uses the magnetic stirring apparatus mix homogeneously in the time of dropping.
2) in the solution of the above-mentioned first step, slowly drip NaOH solution while stirring, stabilize to 9.5 until pH value.
3) above-mentioned system is stirred, leaves standstill, remove supernatant, centrifugalize goes out precipitation, after removing salinity wherein and reach neutrality with the deionized water cyclic washing, puts into the freeze dryer lyophilization, dry thing is ground make dry powder subsequently.
Claims (8)
1, mineralising gene recombinaton collagen composite materials is characterized in that: contain organic composition and mineral in this material, described organic principle is a gene recombinaton collagen, and described mineral is a calcium microcosmic salt crystal.
2, mineralising gene recombinaton collagen composite materials according to claim 1, it is characterized in that: described gene recombinaton collagen, relative molecular weight are 10,000~400,000.
3, according to claim 1,2 described mineralising gene recombinaton collagen composite materials, it is characterized in that: described gene recombinaton collagen is that the segment of choosing human I, II, III, IV, V, VI, XI Collagen Type VI gene is modified the back expression.
4, mineralising gene recombinaton collagen composite materials according to claim 1 is characterized in that: described calcium microcosmic salt crystal comprises hydroxyapatite.
5, the method for preparation mineralising gene recombinaton collagen composite materials as claimed in claim 1, it is characterized in that: described method comprises the following steps:
(1) drip the solution that contains calcium ion in the gene recombinaton collagen solution, make the mass percent concentration of recombinant collagen in the solution finally be 0.3%-30%, the molar concentration of calcium ion finally is 0.01~2mol/L, needs continuous stirring in the dropping process; Can adopt acid or deionized water dissolving for water solublity gene recombinaton collagen, for non-water-soluble employing acid dissolving, used acid is hydrochloric acid, acetic acid, nitric acid, slowly adds the solution that contains calcium ion in this solution, and dripping quantity is that every grammes per square metre group collagen drips calcium ion 0.01~1mol;
(2) drip the aqueous solution contain phosphate anion while stirring slowly in the solution of step (1), the phosphate anion of adding and the mol ratio of calcium ion are Ca: P=1~2: 1;
(3) pH value of dripping alkali liquid adjusting while stirring is 7.4~13 in the solution of step (2);
(4) will leave standstill after the solution stirring, treat precipitation and supernatant layering after, remove supernatant, centrifugalize goes out precipitation, removes the solubility salinity with the deionized water cyclic washing, makes cleaning mixture be neutrality;
(5) precipitate is put into the freeze dryer lyophilization, subsequently dry thing is ground, promptly get described mineralising gene recombinaton collagen composite materials.
6, preparation method according to claim 5 is characterized in that: the solution of the described calcium ions of step (1) is any in calcium hydroxide and the calcium salt, and calcium salt is preferably lime nitrate, calcium chloride;
7, preparation method according to claim 5, it is characterized in that: the solution of the described phosphorus-containing acid ion of step (2) is phosphoric acid and phosphatic any, and phosphate is preferably sodium dihydrogen phosphate, sodium hydrogen phosphate, potassium dihydrogen phosphate, dipotassium hydrogen phosphate, DAP, ammonium di-hydrogen phosphate.
8, preparation method according to claim 5 is characterized in that: the described alkali liquor of step (3) is alkali metal hydroxide or ammonium hydroxide, is preferably sodium hydroxide.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410033774 CN1562391A (en) | 2004-04-16 | 2004-04-16 | Mineralized composite material of gene recombination collagen and preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410033774 CN1562391A (en) | 2004-04-16 | 2004-04-16 | Mineralized composite material of gene recombination collagen and preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1562391A true CN1562391A (en) | 2005-01-12 |
Family
ID=34481390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200410033774 Pending CN1562391A (en) | 2004-04-16 | 2004-04-16 | Mineralized composite material of gene recombination collagen and preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1562391A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100425296C (en) * | 2006-01-05 | 2008-10-15 | 天津市赛宁生物工程技术有限公司 | Collagen base bionic bone matrix |
CN102154786A (en) * | 2011-04-25 | 2011-08-17 | 东南大学 | Mineralized corn protein fibrous membrane and preparation method thereof |
CN102190894A (en) * | 2011-03-25 | 2011-09-21 | 郑州大学 | Method for preparing collagen-based composite material |
CN106492283A (en) * | 2016-11-22 | 2017-03-15 | 北京奥精医药科技有限公司 | A kind of mineralising guide tissue regeneration film and its preparation method and application |
CN111375088A (en) * | 2020-04-29 | 2020-07-07 | 陕西巨子生物技术有限公司 | Double-layer osteochondral tissue repair scaffold and preparation method thereof |
CN114425103A (en) * | 2022-04-06 | 2022-05-03 | 中国科学院苏州纳米技术与纳米仿生研究所 | Bionic biogel and preparation method and application thereof |
-
2004
- 2004-04-16 CN CN 200410033774 patent/CN1562391A/en active Pending
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100425296C (en) * | 2006-01-05 | 2008-10-15 | 天津市赛宁生物工程技术有限公司 | Collagen base bionic bone matrix |
CN102190894A (en) * | 2011-03-25 | 2011-09-21 | 郑州大学 | Method for preparing collagen-based composite material |
CN102154786A (en) * | 2011-04-25 | 2011-08-17 | 东南大学 | Mineralized corn protein fibrous membrane and preparation method thereof |
CN106492283A (en) * | 2016-11-22 | 2017-03-15 | 北京奥精医药科技有限公司 | A kind of mineralising guide tissue regeneration film and its preparation method and application |
CN106492283B (en) * | 2016-11-22 | 2019-07-12 | 北京奥精医药科技有限公司 | A kind of mineralising guide tissue regeneration film and its preparation method and application |
CN111375088A (en) * | 2020-04-29 | 2020-07-07 | 陕西巨子生物技术有限公司 | Double-layer osteochondral tissue repair scaffold and preparation method thereof |
CN111375088B (en) * | 2020-04-29 | 2022-06-14 | 陕西巨子生物技术有限公司 | Double-layer osteochondral tissue repair scaffold and preparation method thereof |
CN114425103A (en) * | 2022-04-06 | 2022-05-03 | 中国科学院苏州纳米技术与纳米仿生研究所 | Bionic biogel and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101695584B (en) | Injectable composite material capable of promoting bone regeneration and repair and preparation method thereof | |
US7163965B2 (en) | Process for producing porous composite materials | |
CN100563727C (en) | The preparation method of a kind of nanometer hydroxyapatite/fibroin-chitosan compound rest | |
CN107213529B (en) | Preparation method of degradable medical high-molecular three-dimensional material for improving adhesion and osteogenic performance of osteoblasts | |
CN1772602A (en) | Carbonic acid type high activity partially crystallized calcium phosphate and its prepn | |
CN102363798A (en) | Preparation process for collagen sponge | |
CN1241654C (en) | Mineralized fibroin material and preparation method | |
CN103157129B (en) | polyamino acid/hydroxyapatite composite hydrogel for bone repair and preparation method thereof | |
CN103877621B (en) | Electrospun fiber-reinforced calcium phosphate bone cement composite material and application thereof | |
CN1203120C (en) | In-situ compounding process of synthesizing nano composite chitosan/hydroxyapatite material | |
CN103690991A (en) | Preparation method of cartilage repair scaffold material | |
CN1836740A (en) | Composite tri-dimensional porous bone tissue engineering stent material and its preparation method and uses | |
CN107158465B (en) | Preparation method of bone scaffold composite material | |
CN102085391A (en) | Hydroxyapatite/chitosan-silk fibroin nanocomposite and preparation method thereof | |
CN1562391A (en) | Mineralized composite material of gene recombination collagen and preparation method | |
CN1294994C (en) | Injectable type collagen-based soft tissue filling material and preparation method thereof | |
CN102504530B (en) | Gamma-polyglutamic acid/hydroxyapatite composite material and preparation method thereof | |
CN1265847C (en) | Mineralized fibrion/macromolecule composite porous material and preparation method | |
CN103656756A (en) | Nano-hydroxyapatite/silk fibroin composite membrane material and preparation method thereof | |
CN104189953B (en) | Sodium alginate-zein/nanometer hydroxyapatite Composite Bone recovery support and preparation method thereof | |
CN108478874B (en) | Preparation method of hydroxyethyl chitosan nano composite bone scaffold material | |
CN105536059A (en) | Self-repairing injectable bone cement and preparation method | |
CN108904883A (en) | A kind of bone reparing biological material and preparation method thereof using abalone shells preparation | |
CN1299778C (en) | Medical surface bioactive ceramic material and its prepn | |
CN109091703B (en) | Rare earth element doped white phosphorus ore/gelatin three-dimensional porous composite material, and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |